Revelation Biosciences Inc’s latest rating changes from various analysts

In a filing, Revelation Biosciences Inc revealed its Director TIDMARSH GEORGE F unloaded Company’s shares for reported $14438.0 on Dec 08. In the deal valued at $0.52 per share,27,771 shares were sold. As a result of this transaction, TIDMARSH GEORGE F now holds 0 shares worth roughly $0.0.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Then, TIDMARSH GEORGE F sold 10,957 shares, generating $7,243 in total proceeds. Upon selling the shares at $0.66, the Director now owns 42,096 shares.

Before that, TIDMARSH GEORGE F sold 1,845 shares. Revelation Biosciences Inc shares valued at $1,199 were divested by the Director at a price of $0.65 per share. As a result of the transaction, TIDMARSH GEORGE F now holds 27,771 shares, worth roughly $77203.37999999999.

Price Performance Review of REVB

On Friday, Revelation Biosciences Inc [NASDAQ:REVB] saw its stock unchanged to $2.78. Over the last five days, the stock has lost -8.70%. Revelation Biosciences Inc shares have fallen nearly -81.49% since the year began. Nevertheless, the stocks have fallen -98.27% over the past one year. While a 52-week high of $126.90 was reached on 01/29/24, a 52-week low of $2.40 was recorded on 02/07/24. SMA at 50 days reached $13.40, while 200 days put it at $21.89. A total of 0.9 million shares were traded, compared to the trading of 0.4 million shares in the previous session.

Levels Of Support And Resistance For REVB Stock

The 24-hour chart illustrates a support level at 2.58, which if violated will result in even more drops to 2.39. On the upside, there is a resistance level at 3.01. A further resistance level may holdings at 3.25. The Relative Strength Index (RSI) on the 14-day chart is 27.75, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.85, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.34%. Stochastics %K at 1.37% indicates the stock is a buying.

How much short interest is there in Revelation Biosciences Inc?

A steep rise in short interest was recorded in Revelation Biosciences Inc stocks on Jan 31, 2024, growing by 0.11 million shares to a total of 0.12 million shares. Yahoo Finance data shows the prior-month short interest on Dec 29, 2023 was 15050.0 shares. There was a rise of 87.48%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 58.07% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.31.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular